Citadel Advisors - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is and the CUSIP is 71426VAK4. A total of 14 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2018$26,000
-93.1%
5,250,000
+320.0%
0.00%
Q3 2018$375,000
-25.0%
1,250,0000.0%0.00%
Q2 2018$500,0000.0%1,250,0000.0%0.00%
Q1 2018$500,000
-3.1%
1,250,0000.0%0.00%
Q4 2017$516,000
-2.5%
1,250,0000.0%0.00%
Q3 2017$529,000
+53.8%
1,250,0000.0%0.00%
Q2 2017$344,000
-5.5%
1,250,0000.0%0.00%
Q1 2017$364,000
+20.9%
1,250,0000.0%0.00%
Q4 2016$301,000
-39.8%
1,250,0000.0%0.00%
-100.0%
Q3 2016$500,000
+56.7%
1,250,0000.0%0.00%
Q2 2016$319,0001,250,0000.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q1 2017
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 10,000,000$1,000,0000.64%
ARMISTICE CAPITAL, LLC 21,760,000$5,723,0000.43%
Avoro Capital Advisors LLC 6,000,000$2,545,0000.15%
Bruce & Co., Inc. 2,000,000$250,0000.05%
ZAZOVE ASSOCIATES LLC 2,000,000$300,0000.03%
Perceptive Advisors 1,000,000$642,0000.02%
TENOR CAPITAL MANAGEMENT Co., L.P. 2,000,000$221,0000.02%
Aisling Capital LLC 2,500,000$16,0000.01%
683 Capital Management, LLC 9,000,000$68,0000.00%
Jefferies Group LLC 5,715,000$57,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders